Artwork for podcast Let’s Talk Medtech
Let's Talk Medtech: Kevin Sayer on Why all eyes are on Dexcom
Episode 4315th June 2022 • Let’s Talk Medtech • Informa Markets
00:00:00 00:29:28

Share Episode

Shownotes

It's no secret that Dexcom is on the rise. From commercials during the Super Bowl, to blockbuster products on the horizon, the company is reaching a new height of popularity in the continuous glucose monitoring space.

Kevin Sayer, Dexcom CEO, talks about the company's new position the space and all the hype surrounding the upcoming G7 CGM sensor. He also gives his thoughts on where CGM technology is headed in this incredible, can't miss conversation.

Follow

Links